Myocardial viability: Nuclear assessment

Echocardiography

Volumn 22, Issue 2, 2005, Pages 155-164

  Mehta, Deval ^a   Iskandrian, Ami E ^a,b  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^b 318 LHRB   (United States)

Author keywords

Coronary artery disease; Heart failure; Hibernation; Radionuclide imaging; Revascularization; SPECT; Viability

Indexed keywords

DOBUTAMINE; FATTY ACID; FLUORODEOXYGLUCOSE; IODINE 123; IODOPHENYLPENTADECANOIC ACID I 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; TECHNETIUM 99M; TETROFOSMIN; THALLIUM 201; TRACER; UNCLASSIFIED DRUG;

CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CORONARY ARTERY RECANALIZATION; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INFORMATION PROCESSING; MYOCARDIAL HIBERNATION; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RADIOISOTOPE DIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT INDICATION;

FLUORODEOXYGLUCOSE F18; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; RADIOPHARMACEUTICALS; TECHNETIUM; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 13444266029     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0742-2822.2005.04031.x     Document Type: Review

References (71)

1. Gheorghiade M, Bonow RO: Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation 1998;97:282-289.
2. Khand A, Gemmel I, Clark AL, et al: Is the prognosis of heart failure improving? J Am Coll Cardiol 2000;36:2284-2286.
3. Pigott JD, Kouchoukos NT, Oberman A, et al: Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985;5:1036-1045.
4. Elefteriades JA, Tolis G Jr, Levi E, et al: Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993;22:1411-1417.
5. Baker DW, Jones R, Hodges J, et al: Management of heart failure III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994;16(272):1528-1534.
6. Fallavollita JA, Perry BJ, Canty JM Jr: 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation 1997;95:1900-1909.
7. Rahimtoola SH: The hibernating myocardium. Am Heart J 1989;117:211-221.
8. Fallavollita JA, Canty JM Jr: Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: Evidence for chronic stunning in pigs. Circulation 1999;99:2798-2805.
9. Samady H, Elefteriades JA, Abbott BG, et al: Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999;100:1298-1304.
10. Bax JJ, Visser FC, Poldermans D, et al: Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 2001;104(12 Suppl 1):1314-1318.
11. Schinkel AF, Bax JJ, Boersma E, et al: How many patients with ischemic cardiomyopathy exhibit viable myocardium? Am J Cardiol 2001;88:561-564.
12. Yamaguchi A, Ino T, Adachi H, et al: Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg 1998;65:434-438.
13. Iskandrian AE, Germano G, VanDecker W, et al: Validation of left ventricular volume measurements by gated SPECT 99mTc-labeled sestamibi imaging. JNucl Cardiol 1998;5:574-578.
14. Dilsizian V, Bonow RO: Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
15. Dilsizian V, Perrone-Filardi P, Arrighi JA, et al: Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 1993;88:941-952.
16. Bax JJ, Visser FC, Poldermans D, et al: Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 42:79-86.
17. Bax JJ, Poldermans D, Elhendy A, et al: Sensitivity, specificity, and predictive accuracies of various noninvasive echniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:141-186.
18. Mori T, Minamiji K, Kurogane H, et al: Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991;32:1718-1724.
19. Marzullo P, Parodi O, Reisenhofer B, et al: Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-172.
20. Ragosta M, Beller GA, Watson DD, et al: Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-1641.
21. Alfieri O, La Canna G, Giubbini R, et al: Recovery of myocardial function. The ultimate target of coronary revascularization. Eur J Cardiothorac Surg 1993;7:325-330.
22. Udelson JE, Coleman PS, Metherall J, et al: Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994;89:2552-2561.
23. Charney R, Schwinger ME, Chun J, et al: Greenberg MA. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 1994;128:864-869.
24. Marzullo P, Sambuceti G, Parodi O, et al: Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: Comparison with postrevascularization functional recovery. J Nucl Cardiol 1995;2:309-316.
25. Senior R, Glenville B, Basu S, et al: Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischaemic left ventricular dysfunction. Br Heart J 1995;74:358-364.
26. Perrone-Filardi P, Pace L, Prastaro M, et al: Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. Circulation 1996;94:2712-2719.
27. Qureshi U, Nagueh SF, Afridi I, et al: Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. Circulation 1997;95:626-635.
28. Nagueh SF, Vaduganathan P, Ali N, et al: Identification of hibernating myocardium: Comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997;29:985-993.
29. Matsunari I, Fujino S, Taki J, et al: Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: Comparison with rest-redistribution thallium-201. J Am Coll Cardiol 1997;29:1226-1233.
30. Cuocolo A, Nicolai E, Petretta M, et al: One-year effect of myocardial revascularization on resting left ventricular function and regional thallium uptake in chronic CAD. J Nucl Med 1997;38:1684-1692.
31. Bax JJ, Visser FC, van Lingen A, et al: Comparison between 360 degrees and 180 degrees data sampling in thallium-201 rest-redistribution single-photon emission tomography to predict functional recovery after revascularization. Eur J Nucl Med 1997;24:516-522.
32. Sciagra R, Bisi G, Santoro GM, et al: Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997;30:384-391.
33. Matsunari I, Fujino S, Taki J, et al: Significance of late redistribution thallium-201 imaging after rest injection for detection of viable myocardium. J Nucl Med 1997;38:1073-1078.
34. Gunning MG, Anagnostopoulos C, Davies G, et al: Simultaneous assessment of myocardial viability and function for the detection of hibernating myocardium using ECG-gated 99Tcm-tetrofosmin emission tomography: A comparison with 201Tl emission tomography combined with cine magnetic resonance imaging. Nucl Med Commun 1999;20:209-214.
35. Sciagra R, Santoro GM, Bisi G, et al: Rest-redistribution thallium-201 SPECT to detect myocardial viability. J Nucl Med 1998;39:384-390.
36. Bax JJ, Cornel JH, Visser FC, et al: Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization. J Nucl Med 1998;39:1481-1486.
37. Pace L, Perrone-Filardi P, Mainenti P, et al: Combined evaluation of rest-redistribution thallium-201 tomography and low-dose dobutamine echocardiography enhances the identification of viable myocardium in patients with chronic coronary artery disease. Eur J Nucl Med 1998;25:744-750.
38. Gunning MG, Anagnostopoulos C, Knight CJ, et al: Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998;98:1869-1874.
39. Sicari R, Varga A, Picano E, et al: Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy with thallium scintigraphy to improve viability detection. Am J Cardiol 1999;83:6-10.
40. Dellegrottaglie S, Perrone-Filardi P, Pace L, et al: Prediction of long-term effects of revascularization on regional and global left ventricular function by dobutamine echocardiography and rest Tl-201 imaging alone and in combination in patients with chronic coronary artery disease. J Nucl Cardiol 2002;9:174-182.
41. Ohtani H, Tamaki N, Yonekura Y, et al: Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990;66:394-399.
42. Dilsizian V, Rocco TP, Freedman NM, et al: Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress- redistribution imaging. N Engl J Med 323:141-146.
43. Tamaki N, Ohtani H, Yamashita K, et al: Metabolic activity in the areas of new fill-in after thallium-201 reinjection: Comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991;32:673-678.
44. Arnese M, Cornel JH, Salustri A, et al: Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995;91:2748-2752.
45. Haque T, Furukawa T, Takahashi M, et al: Identification of hibernating myocardium by dobutamine stress echocardiography: Comparison with thallium-201 reinjection imaging. Am Heart J 1995;130:553-563.
46. Vanoverschelde JL, D'Hondt AM, Marwick T, et al: Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432-442.
47. Bax JJ, Cornel JH, Visser FC, et al: Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxy-glucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28:558-564.
48. Kostopoulos KG, Kranidis AI, Bouki KP, et al: Detection of myocardial viability in the prediction of improvement in left ventricular function after successful coronary revascularization by using the dobutamine stress echocardiography and quantitative SPECT rest-redistribution-reinjection 201Tl imaging after dipyridamole infusion. Angiology 1996;47:1039-1046.
49. Taki J, Nakajima K, Matsunari I, et al: Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997;38:1503-1510.
50. Lipiecki J, Maublant JC, Citron B, et al: Comparable uptake of thallium-201 and technetium-99m MIBI in hibernating and "maimed" myocardium. Am J Cardiol 1997;80:940-943.
51. Gursurer M, Pinarli AE, Aksoy M, et al: Assessment of viable myocardium and prediction of postoperative improvement in left ventricular function in patients with severe left ventricular dysfunction by quantitative planar stress-redistribution-reinjection 201-T1 imaging. Int J Cardiol 199731(58):179-184.
52. Levine MG, McGill CC, Ahlberg AW, et al: Functional assessment with electrocardiographic: gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999;83:1-5.
53. Marzullo P, Sambuceti G, Parodi O: The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992;33:1925-1930.
54. Maublant JC, Citron B, Lipiecki J, et al: Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium. Am Heart J 1995;129:306-314.
55. Gonzalez P, Massardo T, Munoz A, et al: Is the addition of ECG gating to technetium-99m sestamibi SPET of value in the assessment of myocardial viability? An evaluation based on two-dimensional echocardiography following revascularization. Eur J Nucl Med 1996;23:1315-1322.
56. Maes AF, Borgers M, Flameng W, et al: Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997;29:62-68.
57. Dakik HA, Howell JF, Lawrie GM, et al: Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997;96:2892-2898.
58. Levine MG, McGill CC, Ahlberg AW, et al: Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999;83:1-5.
59. Bisi G, Sciagra R, Santoro GM, et al: Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-1289.
60. Maurea S, Cuocolo A, Soricelli A, et al: Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995;36:1945-1952.
61. Bisi G, Sciagra R, Santoro GM, et al: Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995;36:1994-2000.
62. Greco C, Tanzilli G, Ciavolella M, et al: Nitroglycerin-induced changes in myocardial sestamibi uptake to detect tissue viability: Radionuclide comparison before and after revascularization. Coron Artery Dis 1996;7:877-884.
63. Li ST, Liu XJ, Lu ZL, et al: Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization. J Nucl Cardiol 1996;3:457-463.
64. Schneider CA, Voth E, Gawlich S, et al: Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: Importance of infarct location adjusted thresholds. J Am Coll Cardiol 1998;32:648-654.
65. Leoncini M, Sciagra R, Bellandi F, et al: Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy. J Nucl Cardiol 2002;9:402-406.
66. Bax JJ, Patton JA, Poldermans D, et al: 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: Cardiac applications. Semin Nucl Med 2000;30:281-298.
67. Iskandrian AS, Powers J, Cave V, et al: Assessment of myocardial viability by dynamic tomographic iodine 123 iodophenylpentadecanoic acid imaging: Comparison with rest-redistribution thallium 201 imaging. J Nucl Cardiol 1995;2:101-109.
68. Verani MS, Taillefer R, Iskandrian AE, et al: 123I-IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multicenter IPPA Viability Trial Investigators. 123I- iodophenylpentadecanoic acid. J Nucl Med 2000;41:1299-1307.
69. Narula J, Dawson MS, Singh BK, et al: Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy. J Am Coll Cardiol 2000;36:1913-1918.
70. Allman KC, Shaw LJ, Hachamovitch R, et al: Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002;39:1151-1158.
71. Matsunari I, Boning G, Ziegler SI, et al: Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: Comparison with positron emission tomography using 18F-fluorodeoxyglucose. J Am Coll Cardiol 32:927-935.